Desloratadine - Merck & Co
Alternative Names: Aerius; Allex; Azomyr; Clarinex; Clarinex Reditabs; Clarinex-D 12 Hour; DCL; Decarboethoxyloratadine; Desalex; Descarboethoxyloratadine; Di Heng Sai; MK-4117; Neoclarityn; Opulis; SCH-34117Latest Information Update: 05 Nov 2023
At a glance
- Originator Sepracor
- Developer Merck & Co
- Class Antiallergics; Dibenzocycloheptenes; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Atopic dermatitis; Chronic urticaria; Dermatitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis
- Discontinued Asthma